an introduction to the creative biomart company

An Introduction toThe Creative Biomart

Company

Who We Are

• Creative Biomart provides quality recombinant proteins, diagnostic antibodies and antigens, diagnostic enzymes and pharmaceutical enzymes to the research community of biology, clinical research, molecular diagnostics and biopharmaceutical drug development.

What We Do

• We are offering more than 1,000 recombinant proteins, peptides and antibodies. All the products are rigorously tested to meet the most demanding research needs. At the same time, lowest prices in the industry are always guaranteed.

Also, in order to leverage our core competencies and resources, Creative Biomart has formed a large number of corporate partnerships and academic collaborations for product development and distribution. We welcome potential partners and distributors to explore business relationships with Creative Biomart.

The Creative Biomart Company —unique in the biotech industry…

The Creative Biomart Company — a pioneer in the biotech industry…

We also provide services

Protein LabelingMutagenesis ServicesProtein ExpressionProtein EngineeringMembrane Protein ServicesPEGylation Services

Part of Proprietary Technology Platforms of Creative Biomart

YeastXceedTM Technology selects stable and durable production strains that resemble mammalian system are employed for high-yield, high-productivity protein processing, thus dramatically reducing the associated costs and inherent time requirements.

HostOptimTM technology enables generation of high yielding production systems across different industry relevant platforms (e.g. CHO, HEK, Pichiapastoris). Creative Biomart have identified DNA elements which are instrumental in increasing translation rates when included in recombinant protein expression vectors.

PEG-CtrlTM is a novel site-selective PEGylation platform, using a proprietary efficient and cost-effective PEGylation chemistry, which is suitable to a large variety of proteins. The PEG-CtrlTM unique approach enables homogeneous PEGylated populations where the specific PEGylation site can be selected and controlled, thus improving efficacy compared to existing PEGylation techniques, decreasing cost of goods and substance dosed to patient; while still providing an improved ADME profile due to the addition of the PEG moiety.

Contact

45-16 Ramsey Road, Shirley, NY 11967, USATEL: 1-631-559-9269FAX: 1-631-938-8127EMAIL: info@creative-biomart.com

St John's Innovation Centre, Cowley Road, Cambridge CB4 0WS, UKTEL: 44-207-048-3343

Creative Biomart